Advertisement
Advertisement

ADTX

ADTX logo

Aditxt Inc

0.24
USD
-0.0237
-8.99%
Dec 18, 15:59 UTC -5
Closed
...

Aditxt Inc Profile

About

Aditx Therapeutics Inc. is a life sciences company. It engages in developing biotechnologies specifically focused on health of the immune system through immune monitoring and reprogramming. Aditx Therapeutics Inc. is based in LOMA LINDA, CA.

Info & Links

CEO

Amro Albanna

Headquarters

737 N. FIFTH STREET, SUITE 200
RICHMOND, VA 23219, UNITED STATES

Auditor

dbbmckennon

Share holders

168

Employees

47

Aditxt Inc Statistics

Valuation Measures

Market Capitalization2

3.42M

Enterprise Value

9.74M

Enterprise Value/EBITDA(ttm)

-0.33

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

7.68

Price to Book(mrq)

0.33

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

-1726.96%

Operating Margin(ttm)

--

Profit Margin(ttm)

-59165.59%

Return on Equity(ttm)

-439.07%

Return on Invested Capital(ttm)

-497.50%

Return on Assets(ttm)

-122.96%

Income Statement

Revenue(ttm)

329.80K

Revenue Per Share(ttm)

3.66

Gross Profit(ttm)

-152.00K

EBITDA(ttm)3

-29.15M

Net Income Available to Common(ttm)

-43.31M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.16

52-Week Change

-99.85%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

90.07K

Dividend Yield

0.00%

Float4

13.99M

% Held by Insiders

1.72%

% Held by Institutions

15.54%

Balance Sheet

Total Cash(mrq)

91.20K

Total Cash Per Share(mrq)

1.01

Total Debt(mrq)

6.41M

Total Debt/Equity(mrq)

198.69%

Current Ratio(mrq)

0.09%

Quick Ratio(mrq)

0.08%

Book Value Per Share(mrq)

8.37

Cash Flow

Operating Cash Flow Per Share(ytd)

-91.77

Free Cash Flow(ytd)

-10.62M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement